Solving the Global Opioid Crisis: Incorporating Genetic Addiction Risk Assessment with Personalized Dopaminergic Homeostatic Therapy and Awareness Integration Therapy.
Zeine F, Jafari N, Baron D, Bowirrat A, Pinhasov A, Norling B, Martinez K, Nami M, Manavi N, Sunder K, Rabin D, Bagchi D, Khalsa J, Gold M, Sipple D, Barzegar M, Bodhanapati J, Khader W, Carney P, Dennen C, Gupta A, Elman I, Badgaiyan R, Modestino E, Thanos P, Hanna C, McLaughlin T, Cadet J, Soni D, Braverman E, Barh D, Giordano J, Edwards D, Ashford J, Gondre-Lewis M, Gilley E, Murphy K, Lewandrowski K, Sharafshah A, Makale M, Fuehrlein B, Blum K. Solving the Global Opioid Crisis: Incorporating Genetic Addiction Risk Assessment with Personalized Dopaminergic Homeostatic Therapy and Awareness Integration Therapy. Journal Of Neuroimaging In Psychiatry And Neurology 2024, 8: 50-95. PMID: 39635461, PMCID: PMC11615735.Peer-Reviewed Original ResearchCenters for Disease Control and PreventionSubstance use disordersOpioid crisisOpioid substitution therapyGenetic Addiction Risk SeveritySubstance Abuse and Mental Health Services AdministrationIntegrative therapiesMental Health Services AdministrationDisease Control and PreventionHealth Services AdministrationControl and PreventionIllicit drug useWeb of Science databasesServices AdministrationComprehensive treatment approachHarm reductionDopamine homeostasisSystematic reviewNational surveyRelevant articlesBrain Reward CascadeMortality tollOverdose deathsGoogle ScholarProvisional figures